ABVC BioPharma (ABVC) Competitors $0.86 -0.12 (-11.86%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.87 +0.02 (+1.75%) As of 04/17/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABVC vs. SKYE, TNYA, IMMX, OKUR, ANEB, AADI, RPTX, CUE, ITRM, and ATNMShould you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Skye Bioscience (SKYE), Tenaya Therapeutics (TNYA), Immix Biopharma (IMMX), OnKure Therapeutics (OKUR), Anebulo Pharmaceuticals (ANEB), Aadi Bioscience (AADI), Repare Therapeutics (RPTX), Cue Biopharma (CUE), Iterum Therapeutics (ITRM), and Actinium Pharmaceuticals (ATNM). These companies are all part of the "pharmaceutical products" industry. ABVC BioPharma vs. Skye Bioscience Tenaya Therapeutics Immix Biopharma OnKure Therapeutics Anebulo Pharmaceuticals Aadi Bioscience Repare Therapeutics Cue Biopharma Iterum Therapeutics Actinium Pharmaceuticals ABVC BioPharma (NASDAQ:ABVC) and Skye Bioscience (NASDAQ:SKYE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment. Does the media favor ABVC or SKYE? In the previous week, Skye Bioscience had 15 more articles in the media than ABVC BioPharma. MarketBeat recorded 20 mentions for Skye Bioscience and 5 mentions for ABVC BioPharma. Skye Bioscience's average media sentiment score of 0.64 beat ABVC BioPharma's score of -0.04 indicating that Skye Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ABVC BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Skye Bioscience 3 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of ABVC or SKYE? 11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 21.1% of Skye Bioscience shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by company insiders. Comparatively, 3.0% of Skye Bioscience shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has higher valuation & earnings, ABVC or SKYE? ABVC BioPharma has higher revenue and earnings than Skye Bioscience. Skye Bioscience is trading at a lower price-to-earnings ratio than ABVC BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$509.79K26.46-$10.52M-$0.47-1.82Skye BioscienceN/AN/A-$37.65M-$0.72-1.99 Which has more volatility and risk, ABVC or SKYE? ABVC BioPharma has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Comparatively, Skye Bioscience has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Does the MarketBeat Community favor ABVC or SKYE? Skye Bioscience received 14 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/ASkye BioscienceOutperform Votes14100.00% Underperform VotesNo Votes Do analysts prefer ABVC or SKYE? Skye Bioscience has a consensus target price of $16.60, suggesting a potential upside of 1,056.79%. Given Skye Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Skye Bioscience is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Skye Bioscience 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ABVC or SKYE more profitable? Skye Bioscience has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. Skye Bioscience's return on equity of -45.78% beat ABVC BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-1,619.65% -104.94% -56.81% Skye Bioscience N/A -45.78%-37.44% SummarySkye Bioscience beats ABVC BioPharma on 11 of the 16 factors compared between the two stocks. Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVC vs. The Competition Export to ExcelMetricABVC BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.49M$6.44B$5.30B$7.34BDividend YieldN/A3.21%5.45%4.30%P/E Ratio-0.996.8921.8617.80Price / Sales26.46230.51380.5297.73Price / CashN/A65.6738.2634.64Price / Book0.845.936.453.98Net Income-$10.52M$142.99M$3.22B$247.81M1 Month Performance29.55%-13.57%-9.71%-7.84%1 Year Performance-13.65%-8.90%11.52%1.60% ABVC BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVCABVC BioPharma0.852 of 5 stars$0.86-11.9%N/A-18.6%$13.49M$509,788.00-0.9930Earnings ReportGap UpSKYESkye Bioscience1.1903 of 5 stars$1.39+6.9%$18.00+1,195.0%-91.5%$43.06MN/A-1.9311Analyst RevisionNews CoverageTNYATenaya Therapeutics3.0501 of 5 stars$0.48-3.7%$6.25+1,201.8%-89.5%$42.05MN/A-0.33110Gap UpHigh Trading VolumeIMMXImmix Biopharma2.2588 of 5 stars$1.51+0.7%$7.00+363.6%-24.9%$41.86MN/A-1.789OKUROnKure Therapeutics2.4892 of 5 stars$3.09-1.3%$32.33+946.4%N/A$41.52MN/A-0.25N/AGap DownHigh Trading VolumeANEBAnebulo Pharmaceuticals2.792 of 5 stars$1.01-1.0%$8.00+692.1%-63.3%$41.50MN/A-3.614Short Interest ↓Positive NewsGap UpAADIAadi Bioscience0.9235 of 5 stars$1.66+1.2%$1.67+0.4%-12.8%$41.00M$25.07M-0.7340RPTXRepare Therapeutics3.1118 of 5 stars$0.96-4.0%$4.50+368.9%-60.3%$40.80M$53.48M-0.48180Short Interest ↓Gap DownCUECue Biopharma4.3213 of 5 stars$0.63-7.3%$4.75+659.0%-51.8%$39.64M$9.53M-0.7060ITRMIterum Therapeutics1.3881 of 5 stars$1.11-1.8%$5.00+350.5%-24.5%$38.39MN/A-0.8510Gap DownATNMActinium Pharmaceuticals1.8793 of 5 stars$1.22-5.4%$7.40+506.6%N/A$38.06M$81,000.00-0.8830Analyst Upgrade Related Companies and Tools Related Companies Skye Bioscience Competitors Tenaya Therapeutics Competitors Immix Biopharma Competitors OnKure Therapeutics Competitors Anebulo Pharmaceuticals Competitors Aadi Bioscience Competitors Repare Therapeutics Competitors Cue Biopharma Competitors Iterum Therapeutics Competitors Actinium Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABVC) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABVC Stock Free ABVC Stock Alerts